Trademark: 79325856
Word
QUIBIM
Status Date
Tuesday, September 20, 2022
Registration Number
6848940
Registration Date
Tuesday, September 20, 2022
Filing Date
Friday, April 23, 2021
Published for Opposition
Tuesday, July 5, 2022
9 Downloadable cloud-based software platform and management computer software, namely, downloadable software for medical image database management; downloadable storage software for use in the electronic storage of data, images and files; medical image processing software, namely, downloadable software for processing medical images; image biomarker extraction software, namely, downloadable software for extracting imaging biomarkers; downloadable software for processing digital anatomy images for biomarker imaging diagnosis and treatment; downloadable software for medical image equipment; downloadable cloud computing software; downloadable data management software; downloadable image management software; computer programs relating to the medical field, namely, downloadable computer programs for controlling medical imaging equipment; raster image processors; image recognition software, namely, downloadable software for image recognition; downloadable software for generating virtual images; downloadable computer software for processing digital images; software for use in systems supporting medical decision making, namely, downloadable software for medical imaging; downloadable computer software for data storage automation
44 Medical services; provision of information, advice and data, namely, medical information regarding medical images; medical imaging services and image biomarker extraction in the nature of medical imaging services; medical diagnostic imaging; medical imaging services; advisory services relating to medical problems; information and advice services in the field of health, namely, advisory services relating to health care; provision of medical information; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes
42 Scientific and technological services as well as research and design services related thereto, namely, providing temporary use of on-line non-downloadable software and applications for processing digital anatomy images for biomarker imaging diagnosis and treatment, platform as a service (paas) featuring computer software platforms for processing digital anatomy images for biomarker imaging diagnosis and treatment, and namely software as a service (saas) services featuring software for processing digital anatomy images for biomarker imaging diagnosis and treatment; industrial or scientific analysis and research services for medical purposes, namely, providing temporary use of on-line non-downloadable software and applications for processing digital anatomy images for biomarker imaging diagnosis and treatment, platform as a service (paas) featuring computer software platforms for processing digital anatomy images for biomarker imaging diagnosis and treatment, and software as a service (saas) services featuring software for processing digital anatomy images for biomarker imaging diagnosis and treatment; engineering services; provision of scientific expertise, namely, providing information about scientific research; research and development services in the field of medicine for clinical pathology diagnosis; electronic data storage of medical records; design and development of computer software for image processing; technological and scientific services, namely, scientific research in the field of medical imaging; scientific research for medical purposes; provision of scientific information regarding medical disorders and their treatment; scientific industrial analysis and research services in the field of medical imaging; computer-aided industrial analysis services, namely, providing temporary use of on-line non-downloadable software and applications for processing digital anatomy images for biomarker imaging diagnosis and treatment, platform as a service (paas) featuring computer software platforms for processing digital anatomy images for biomarker imaging diagnosis and treatment, and software as a service (saas) services featuring software for processing digital anatomy images for biomarker imaging diagnosis and treatment; engineering drawing; medical and pharmacological research services; conducting clinical trials for others
The mark consists of a geometric design comprised of multiple shaded squares where the colors go from green to blue, to orange, to yellow, to red from top to bottom. To the right of this is the wording "QUIBIM" in black. The color white represents background and/or transparent areas and is not a feature of the mark.
The color(s) green, blue, orange, yellow, red, and black is/are claimed as a feature of the mark.
Feb 1, 2023
Final Decision Transaction Processed By Ib
Jan 10, 2023
Final Disposition Notice Sent To Ib
Jan 10, 2023
Final Disposition Processed
Dec 20, 2022
Final Disposition Notice Created, To Be Sent To Ib
Dec 2, 2022
Limitation From The Ib Examined, No Action Is Needed
Sep 20, 2022
Notice Of Registration Confirmation Emailed
Sep 20, 2022
Registered-Principal Register
Jul 30, 2022
Limitation Of Goods Received From Ib
Jul 19, 2022
Notification Processed By Ib
Jul 5, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 5, 2022
Published For Opposition
Jun 29, 2022
Notification Of Possible Opposition Sent To Ib
Jun 29, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jun 15, 2022
Notification Of Notice Of Publication E-Mailed
May 31, 2022
Approved For Pub - Principal Register
May 26, 2022
Teas/Email Correspondence Entered
May 25, 2022
Correspondence Received In Law Office
May 25, 2022
Teas Response To Office Action Received
May 25, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 25, 2022
Teas Change Of Correspondence Received
May 25, 2022
Teas Change Of Domestic Representatives Address
May 25, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 25, 2022
Teas Change Of Owner Address Received
Jan 30, 2022
Refusal Processed By Ib
Jan 13, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jan 13, 2022
Refusal Processed By Mpu
Dec 21, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Dec 20, 2021
Non-Final Action Written
Dec 20, 2021
Assigned To Examiner
Nov 23, 2021
Application Filing Receipt Mailed
Nov 19, 2021
New Application Office Supplied Data Entered
Nov 18, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
